Clinical Trial Update: Multiple Dose Japanese Bridging Study [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose Japanese bridging study for an Alzheimer's disease candidate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED